secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001493152-24-009895
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 3.02, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics completes $18.16M Series B Preferred offering and exchange of Series A/A-1 shares
--------------------------------------------------------------------------------

- Gross proceeds of $18.16M: $12.495M from new subscriptions and $5.67M from Series A-1 sales immediately exchanged.
- Series B Preferred convertible at $1.2444 per share; mandatory conversion on Mar 13, 2026 or if VWAP >$8 for 20 of 30 days.
- Annual dividends: 20% of conversion shares on Mar 13, 2025 and Mar 13, 2026; accelerated on fundamental transactions.
- Beneficial ownership limited to 4.99% (or 9.99% at holder election); primary market cap of 19.99% of outstanding common.
- All outstanding Series A and A-1 Preferred exchanged; 44,285 Series B shares outstanding after close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315224009895/0001493152-24-009895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315224009895/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer